Skip to main content
OpenTrials
Completed

NCT Number: NCT02638025

Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury

This study use anterior segment spectral-domain optical coherence tomography (SD-OCT) to exam patients with closed globe injury, and compared with slit lamp examination. The results showed that OCT can identify features of closed globe injury that were otherwise not visible on slit lamp biomicroscopy.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The anterior segment architecture changes of closed globe injury patients include corneal damage, hyphema, angle recession and lens dislocation, which can be showed with OCT. OCT was superior to slit lamp biomicroscopy examination in detecting anterior segment architecture changes, especially in the presence of media opacities.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with closed globe injury were recruited; had hyphema at least 1/3 of anterior chamber volume

Exclusion criteria

  • can not cooperate with examination

Treatment and study plan

OCT

Device

Anterior Segment Spectral-domain Optical Coherence Tomography

Primary outcomes

  1. anterior segment spectral-domain optical coherence tomography (SD-OCT) findings in patients with closed globe injury

    Time frame: within 24 hours after patients were admitted

Sponsors and collaborators

Lead sponsor

Huizhou Municipal Central Hospital

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2015
First posted
Dec 22, 2015
Registry last updated
Dec 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.